Initial experience with dabigatran etexilate at Auckland City Hospital.
Sarah
S
Bell
Jessica
J
Nand
David
D
Spriggs
Laura
L
Young
Matthew
M
Dawes
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D058833:Antithrombin Proteins / Q000009:adverse effects* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D001562:Benzimidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D000069604:Dabigatran; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced*; D006786:Hospitals, Urban; D006801:Humans; D008297:Male; D008875:Middle Aged; D009520:New Zealand; D018579:Patient Selection; D011725:Pyridines / Q000009:adverse effects* / Q000627:therapeutic use; D051437:Renal Insufficiency / Q000150:complications; D012189:Retrospective Studies
D058833:Antithrombin Proteins; D001562:Benzimidazoles; D011725:Pyridines; D000069604:Dabigatran